Related Experiment Videos
p53 protein expression in cutaneous T-cell lymphomas
A F Lauritzen1, G L Vejlsgaard, K Hou-Jensen
1Department of Pathology, Herlev Hospital, University of Copenhagen, Denmark.
The British Journal of Dermatology
|July 1, 1995
Summary
Mutations in the p53 tumor suppressor gene are linked to high-grade cutaneous T-cell lymphomas (CTCL). Low-grade CTCL showed minimal p53 protein expression, suggesting p53 alterations are not critical in early-stage disease.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- The p53 gene acts as a tumor suppressor, and its mutations are common in human cancers.
- Mutated p53 protein accumulates in cells, making it detectable via immunohistochemistry.
- Cutaneous T-cell lymphomas (CTCL) are a group of malignant skin conditions with varying grades of severity.
Purpose of the Study:
- To investigate the expression of p53 protein in different grades of cutaneous T-cell lymphomas (CTCL).
- To determine the potential role of p53 alterations in the pathogenesis of CTCL.
- To correlate p53 expression levels with lymphoma grade.
Main Methods:
- Utilized a monoclonal anti-p53 antibody (clone DO7) for immunohistochemical analysis.
- Examined p53 protein expression in 25 CTCL samples, including mycosis fungoides, Sézary's syndrome, and large cell lymphomas.
- Categorized lymphomas into low-grade and high-grade subtypes for comparative analysis.
Main Results:
- Easily detectable p53 protein was found in a significant proportion of neoplastic cells in half of the high-grade lymphomas.
- Low-grade lymphomas (mycosis fungoides, Sézary's syndrome) exhibited minimal to no p53-positive neoplastic cells.
- A clear distinction in p53 expression was observed between high-grade and low-grade CTCL subtypes.
Conclusions:
- Molecular and/or genetic alterations of p53 are likely involved in the development of high-grade CTCL.
- p53 gene alterations appear to play a minor role in the pathogenesis of low-grade CTCL.
- p53 protein expression levels can serve as a potential biomarker differentiating CTCL grades.